RACHEL OLIVER: Open Payments
NPI 1013660323 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$133 in 7 payments from 6 companies in 2025. Trend: 2023 $140 · 2024 $766 · 2025 $133
Food & beverage: $133
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $44 |
| GENZYME CORPORATION | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: RINVOQ, DUPIXENT, TREMFYA, XELJANZ, LINZESS, ENTYVIO, ZENPEP.
Industry payments across FL — which companies pay providers there.
